Literature DB >> 7516803

Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.

M Grous1, M Barnette.   

Abstract

1. The ability of various phosphodiesterase (PDE) inhibitors to reduce the initial and/or late response to ovalbumin (OVA) in isolated strips of guinea-pig colonic smooth muscle from sensitized animals was examined. 2. Both the initial and late responses to OVA (0.05 mg ml-1) were inhibited by the non-selective PDE inhibitor, 3-isobutyl-1-methyl-xanthine (IBMX, EC50 = 26.0 and 6.1 microM, respectively), and the selective inhibitors of low Km cyclic AMP specific PDE (PDE IV), (R)- and (S)-rolipram. The (S)-isomer (EC50 = approximately 1.0 microM for both responses) was about 10 fold less potent than the (R)-isomer (EC50 = approximately 0.1 microM for both responses). 3. Zaprinast, a selective inhibitor of the cyclic GMP-specific PDE (PDE V) inhibited only the late response (EC50 = 1.4 microM). 4. SK&F 94120, a selective inhibitor of the cyclic GMP-inhibited low Km cyclic AMP PDE (PDE III), inhibited the initial response (45.9 +/- 11.9%, P < 0.05) at the highest concentration tested (100 microM), and had no effect on the late response. 5. The results suggest that PDE inhibitors, especially PDE IV inhibitors, can attenuate the contractile response of guinea-pig colon to OVA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516803      PMCID: PMC1909999          DOI: 10.1111/j.1476-5381.1994.tb14053.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

Review 1.  Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.

Authors:  C D Nicholson; R A Challiss; M Shahid
Journal:  Trends Pharmacol Sci       Date:  1991-01       Impact factor: 14.819

2.  Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.

Authors:  T J Torphy; L B Cieslinski
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

3.  Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle.

Authors:  P J Silver; L T Hamel; M H Perrone; R G Bentley; C R Bushover; D B Evans
Journal:  Eur J Pharmacol       Date:  1988-05-20       Impact factor: 4.432

4.  Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.

Authors:  T J Torphy; H L Zhou; M Burman; L B Huang
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

5.  Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.

Authors:  N Frossard; Y Landry; G Pauli; M Ruckstuhl
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

6.  Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation.

Authors:  J E Souness; C M Carter; B K Diocee; G A Hassall; L J Wood; N C Turner
Journal:  Biochem Pharmacol       Date:  1991-07-25       Impact factor: 5.858

7.  Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.

Authors:  B J Undem; P T Peachell; L M Lichtenstein
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

8.  Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst.

Authors:  C P Nielson; R E Vestal; R J Sturm; R Heaslip
Journal:  J Allergy Clin Immunol       Date:  1990-11       Impact factor: 10.793

9.  Antigen-induced contraction of jejunal smooth muscle in the sensitized rat.

Authors:  D L Vermillion; P B Ernst; R Scicchitano; S M Collins
Journal:  Am J Physiol       Date:  1988-12

10.  Relaxant effects of forskolin in smooth muscle. Role of cyclic AMP.

Authors:  M J Muller; H P Baer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-02       Impact factor: 3.000

View more
  3 in total

1.  Effects of selective phosphodiesterase 3 inhibition in the perfused liver of the rat after endotoxin treatment.

Authors:  H Weidenbach; K Beckh; M Burger; T Schricker; M Georgieff; G Adler
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.

Authors:  S M Yu; S C Kuo
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

3.  Effect of phosphodiesterase-4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model.

Authors:  FangTing Yuan; HaiXia Ren; Wei Tan; Ying Wang; HeSheng Luo
Journal:  Neurogastroenterol Motil       Date:  2022-01-17       Impact factor: 3.960

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.